Effect of antidiabetics on the risk of hepatocellular carcinoma in patients with diabetes and metabolic dysfunction-associated steatotic liver disease

被引：0
|
作者：
Lee, Han Ah [1 ]
Kim, Hwi Young [1 ]
Seo, Yeon Seok [2 ]
Ahn, Sang Hoon [3 ]
Kim, Seung Up [3 ]
机构：
[1] Ewha Womans Univ Coll Med, Seoul, South Korea
[2] Korea Univ Coll Med, Seoul, South Korea
[3] Yonsei Univ Coll Med, Seoul, South Korea
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-246
引用
收藏
页码：S481 / S481
页数：1
相关论文
共 50 条
  • [1] Risk factors for hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease
    Liew, Ian Yang
    Phua, Hwee Pin
    Lim, Wei Yen
    Chow, Angela
    Loo, Xiu Ying
    Sim, Kevin
    Lee, Eng Sing
    Yew, Kuo Chao
    JOURNAL OF HEPATOLOGY, 2024, 80 : S497 - S498
  • [2] Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Rodriguez, Luis A.
    Schmittdiel, Julie A.
    Liu, Liyan
    Macdonald, Brock A.
    Balasubramanian, Sreepriya
    Chai, Krisna P.
    Seo, Suk I.
    Mukhtar, Nizar
    Levin, Theodore R.
    Saxena, Varun
    JAMA NETWORK OPEN, 2024, 7 (07) : e2421019
  • [3] Risk Stratification of Patients with Metabolic Dysfunction-associated Steatotic Liver Disease Steatohepatitis, Fibrosis, and Hepatocellular Carcinoma
    El-Kassas, Mohamed
    Othman, Heba A.
    Elbadry, Mohamed
    Alswat, Khalid
    Yilmaz, Yusuf
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2025, 15 (01)
  • [4] Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease
    Stefan, Norbert
    Roden, Michael
    DIABETOLOGIE UND STOFFWECHSEL, 2024, 19 : S290 - S296
  • [5] Phenotypes of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatocellular Carcinoma
    Esteban, Jesus Rivera-
    Munoz-Martinez, Sergio
    Higuera, Monica
    Sena, Elena
    Bermudez-Ramos, Maria
    Banares, Juan
    Martinez-Gomez, Maria
    Cusido, M. Serra
    Jimenez-Masip, Alba
    Francque, Sven M.
    Tacke, Frank
    Minguez, Beatriz
    Pericas, Juan M.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (09)
  • [6] Modifiable Risk Factors for Hepatocellular Carcinoma in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-Analysis
    Xiao, Shiyu
    Liu, Ya
    Fu, Xiliang
    Chen, Tong
    Xie, Wenhui
    AMERICAN JOURNAL OF MEDICINE, 2024, 137 (11):
  • [7] A male mouse model for metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma
    Jeong, Byung-Kwan
    Choi, Won-Il
    Choi, Wonsuk
    Moon, Jieun
    Lee, Won Hee
    Choi, Chan
    Choi, In Young
    Lee, Sang-Hyun
    Kim, Jung Kuk
    Ju, Young Seok
    Kim, Pilhan
    Moon, Young-Ah
    Park, Jun Yong
    Kim, Hail
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [8] Chemoprevention of hepatocellular carcinoma associated with metabolic dysfunction-associated steatotic liver disease: an updated review
    Dickinson, Averie
    Dinani, Amreen
    Wegermann, Kara
    HEPATOMA RESEARCH, 2024, 10
  • [9] Pathogenic Mechanisms of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Associated Hepatocellular Carcinoma
    Nakamura, Toru
    Masuda, Atsutaka
    Nakano, Dan
    Amano, Keisuke
    Sano, Tomoya
    Nakano, Masahito
    Kawaguchi, Takumi
    CELLS, 2025, 14 (06)
  • [10] Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma
    Song, Byeong Geun
    Choi, Sung Chul
    Goh, Myung Ji
    Kang, Wonseok
    Sinn, Dong Hyun
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Paik, Seung Woon
    JHEP REPORTS, 2023, 5 (09)
12345